The overall ratings of 7 Health Care Equipment & Supplies stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
Analogic Corporation (ALOG) is having a tough week. The company’s rating falls from a C to a D. Analogic Corporation is a technology company that designs and manufactures medical imaging and security systems and subsystems that are used primarily in the healthcare and airport security markets. The company also gets F’s in sales growth and earnings revisions. For more information, get Portfolio Grader’s complete analysis of ALOG stock.
This week, DexCom, Inc.’s (DXCM) rating worsens to a D from the company’s C rating a week ago. DexCom, Inc. is a medical device company focused on the design and development of continuous glucose monitoring systems for people with diabetes. The company also gets F’s in earnings revisions, earnings surprise, and return on equity. For more information, get Portfolio Grader’s complete analysis of DXCM stock.
Abbott Laboratories (ABT) slips from a C to a D this week. Abbott Laboratories discovers, develops, manufactures, and sells health care products. The company also gets F’s in earnings momentum. For more information, get Portfolio Grader’s complete analysis of ABT stock.
This is a rough week for Meridian Bioscience, Inc. (VIVO). The company’s rating falls to D from the previous week’s C. Meridian Bioscience, Inc. manufactures diagnostic test kits, bulk antigens, antibodies and bioresearch reagents used by researchers and other diagnostic manufacturers. For more information, get Portfolio Grader’s complete analysis of VIVO stock.
Slipping from a C to a D rating, Rockwell Medical, Inc. (RMTI) takes a hit this week. Rockwell Medical, Inc. manufactures, markets, and delivers dialysis solutions, powders, and ancillary products to hemodialysis providers. The company also gets F’s in earnings surprise and return on equity. For more information, get Portfolio Grader’s complete analysis of RMTI stock.
Cesca Therapeutics Inc. (KOOL) experiences a ratings drop this week, going from last week’s D to a F. Cesca Therapeutics Inc. designs, manufactures and markets automated and semi-automated devices and single-use processing disposables that enable hospitals and blood banks to manufacture a therapeutic dose of stem cells. The company also gets F’s in sales growth, earnings momentum, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of KOOL stock.
Delcath Systems, Inc. (DCTH) earns a F this week, moving down from last week’s grade of D. Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company. The company also gets F’s in earnings momentum, return on equity, and free cash flow. For more information, get Portfolio Grader’s complete analysis of DCTH stock.
Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.
